FDA Inspection
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) – FDA Inspection, Jul 17, 2019
Record Details
This FDA Inspection record concerns Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), with an inspection on July 17, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- July 17, 2019
- Product Type
- Human Drugs
- People
- Ashley N. Queen (Issuing Officer)
- Michael Shanks (Issuing Officer)
View Company Profile
ID · 88b5a213-2704-4d9d-9dab-8e23447bf8bc
Inspection Facts
- Inspection number
- 1097448
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 19, 2024 | Not classified | Office of Inspections and Investigations | |
| July 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2023 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 20, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 12, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
- FDA Inspection 1242049 - 2024-03-19
- FDA Inspection 1253708 - 2023-07-21
- FDA Inspection 1205732 - 2023-04-19
- FDA Inspection 1155760 - 2020-07-20
- FDA Inspection 1060641 - 2018-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.